We are live on
!
Find out more
Pictet Asset Management Portfolio holdings
AUM
$105B
1-Year Est. Return
38.07%
This Fund
S&P 500
This Quarter
Est. Return
+26.93%
1 Year Est. Return
+38.07%
3 Year Est. Return
+113.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$105B
AUM Growth
+$9.87B
(+10%)
Cap. Flow
-$5.55B
Cap. Flow
% of AUM
-5.31%
Top 10 Holdings %
Top 10 Hldgs %
21.61%
Holding
2,219
New
117
Increased
528
Reduced
975
Closed
77
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertiv
VRT
|
+$446M |
| 2 |
Cisco
CSCO
|
+$406M |
| 3 |
Snowflake
SNOW
|
+$271M |
| 4 |
Visa
V
|
+$220M |
| 5 |
APi Group
APG
|
+$214M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$893M |
| 2 |
Palo Alto Networks
PANW
|
+$583M |
| 3 |
Microsoft
MSFT
|
+$480M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$474M |
| 5 |
Marvell Technology
MRVL
|
+$474M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 39.26% |
| 2 | Industrials | 13.78% |
| 3 | Healthcare | 11.68% |
| 4 | Financials | 8.38% |
| 5 | Consumer Discretionary | 6.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Pebblebrook Hotel Trust
PEB
$2B
| $328K | ﹤0.01% |
16,924
-3,137
| -16% | -$48.4K |
|
1727
Peloton Interactive
PTON
$2.42B
| $328K | ﹤0.01% |
55,433
| – | – |
|
1728
Nektar Therapeutics
NKTR
$2.53B
| $327K | ﹤0.01% |
4,684
+966
| +26% | +$70.7K |
|
|
DHC
1729
Diversified Healthcare Trust
DHC
$2.04B
| $327K | ﹤0.01% |
35,159
| – | – |
|
1730
Klaviyo
KVYO
$5.09B
| $325K | ﹤0.01% |
21,547
| – | – |
|
1731
Kirby Corp
KEX
$7B
| $325K | ﹤0.01% |
2,389
| – | – |
|
|
FINV
1732
FinVolution Group
FINV
$1.11B
| $324K | ﹤0.01% |
67,700
-29,700
| -30% | -$147K |
|
1733
Douglas Emmett
DEI
$1.93B
| $323K | ﹤0.01% |
27,405
| – | – |
|
1734
Sunstone Hotel Investors
SHO
$2.01B
| $323K | ﹤0.01% |
28,228
+1,037
| +4% | +$10.9K |
|
1735
UFP Technologies
UFPT
$2.52B
| $323K | ﹤0.01% |
1,217
| – | – |
|
1736
Newmark Group
NMRK
$2.52B
| $321K | ﹤0.01% |
21,272
+112
| +0.5% | +$1.71K |
|
1737
Encore Capital Group
ECPG
$2.01B
| $321K | ﹤0.01% |
3,444
+445
| +15% | +$36.2K |
|
1738
CorVel
CRVL
$3.12B
| $320K | ﹤0.01% |
5,120
| – | – |
|
1739
NeoGenomics
NEO
$2.14B
| $320K | ﹤0.01% |
21,923
| – | – |
|
1740
HCI Group
HCI
$2.3B
| $318K | ﹤0.01% |
1,815
| – | – |
|
1741
Ezcorp Inc
EZPW
$1.67B
| $317K | ﹤0.01% |
9,179
| – | – |
|
1742
Goodyear
GT
$1.74B
| $317K | ﹤0.01% |
48,010
| – | – |
|
1743
Walker & Dunlop
WD
$1.49B
| $316K | ﹤0.01% |
5,783
| – | – |
|
|
NOAH
1744
Noah Holdings
NOAH
$605M
| $316K | ﹤0.01% |
31,600
-10,000
| -24% | -$103K |
|
1745
Horace Mann Educators
HMN
$2.14B
| $314K | ﹤0.01% |
6,084
| – | – |
|
1746
First Commonwealth Financial
FCF
$2.17B
| $314K | ﹤0.01% |
15,453
| – | – |
|
|
SEM
1747
DELISTED
Select Medical
SEM
| $314K | ﹤0.01% |
18,997
| – | – |
|
|
LB
1748
LandBridge Co
LB
$2.27B
| $313K | ﹤0.01% |
3,956
| – | – |
|
|
DX
1749
Dynex Capital
DX
$3.17B
| $313K | ﹤0.01% |
23,872
+2,245
| +10% | +$29.5K |
|
1750
LeMaitre Vascular
LMAT
$1.86B
| $313K | ﹤0.01% |
3,259
| – | – |
|
Similar funds
Pictet Asset Management's Q2 2026 Portfolio in Review
As of Q2 2026, Pictet Asset Management held 2,219 positions worth $105B, up 10% from $94.8B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Pictet Asset Management withdrew a net $5.55B in Q2 2026, closing 77 positions and reducing 975 holdings. Its most notable exit was Terns Pharmaceuticals, an estimated $87.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 35% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Pictet Asset Management opened a new position in Madison Air Solutions worth $173M.
- Pictet Asset Management's largest Q2 2026 buy was Madison Air Solutions: 4,434,713 shares worth $173M.
- Pictet Asset Management added most to Vertiv in Q2 2026, an estimated $446M increase.
- Pictet Asset Management's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $893M.
- Pictet Asset Management fully exited Terns Pharmaceuticals in Q2 2026, selling an estimated $87.3M.
- Pictet Asset Management's ten largest holdings make up 22% of its $105B portfolio in Q2 2026.
- Pictet Asset Management opened 117 new positions and closed 77 in Q2 2026.
- Pictet Asset Management's portfolio value rose 10% quarter-over-quarter to $105B.
Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.